AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 11192477 — intervention group
Group type: EXPERIMENTAL
Intervention: etodolac 400mg in divided doses over 90 minutes
Number of subjects: 24
Study 11192477 — intervention group
Group type: COMPARATOR
Intervention: Delayed absorption (not specified dosage)
Number of subjects: 24
Study 9183496 — intervention group
Group type: EXPERIMENTAL
Intervention: Nucleotide-supplemented preterm formula (NF)
Number of subjects: 40
Study 9183496 — intervention group
Group type: COMPARATOR
Intervention: Regular preterm formula (F)
Number of subjects: 40
Study 1285663 — intervention group
Group type: EXPERIMENTAL
Intervention: Captopril 25 mg orally between the 5th and 7th day post MI, sustained until the end of the study.
Number of subjects: 30
Study 1285663 — intervention group
Group type: EXPERIMENTAL
Intervention: Nifedipine 10 mg capsules t.i.d. started between days 5 and 7 post MI.
Number of subjects: 30
Study 1285663 — intervention group
Group type: COMPARATOR
Intervention: Conventional treatment according to the ICCU routine.
Number of subjects: 30
Study 29283975 — intervention group
Group type: EXPERIMENTAL
Intervention: Phenylephrine
Number of subjects: 19
Study 29283975 — intervention group
Group type: EXPERIMENTAL
Intervention: Nitroprusside
Number of subjects: 19
Study 29283975 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19
Study 28742913 — intervention group
Group type: EXPERIMENTAL
Intervention: Mobile health intervention for infant safe sleep practices
Number of subjects: 1600
Study 28742913 — intervention group
Group type: COMPARATOR
Intervention: Nursing quality improvement intervention
Number of subjects: 1600
Study 28742913 — intervention group
Group type: COMPARATOR
Intervention: Control mobile health intervention for breastfeeding
Number of subjects: 1600
Study 26226166 — intervention group
Group type: EXPERIMENTAL
Intervention: Green tea extract (GTE) 4 g
Number of subjects: 28
Study 26226166 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 28
Study 24217863 — intervention group
Group type: EXPERIMENTAL
Intervention: Expressive writing about life goals
Number of subjects: 46
Study 24217863 — intervention group
Group type: COMPARATOR
Intervention: Control topic (review of a recent book or film)
Number of subjects: 46
Study 21364957 — intervention group
Group type: EXPERIMENTAL
Intervention: 7-day diet/exercise intervention (low saturated fat, low added sugar, high fiber diet; exercise: cycling, six sessions lasting 40-45 min/session at 65% VO2 max)
Number of subjects: 37
Study 21364957 — intervention group
Group type: EXPERIMENTAL
Intervention: 7-day diet/exercise intervention
Number of subjects: 37
Study 21364957 — intervention group
Group type: COMPARATOR
Intervention: Pre-intervention
Number of subjects: 37
Study 18308795 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 mg 5-HTP with CBD
Number of subjects: 15
Study 18308795 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 mg 5-HTP with CBD
Number of subjects: 15
Study 18308795 — intervention group
Group type: EXPERIMENTAL
Intervention: 300 mg 5-HTP with CBD
Number of subjects: 15
Study 18308795 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study 18308795 — intervention group
Group type: EXPERIMENTAL
Intervention: 5-HTP with CBD
Number of subjects: 15
Study 16608859 — intervention group
Group type: EXPERIMENTAL
Intervention: Revascularization within 7 days
Number of subjects: 13451
Study 16608859 — intervention group
Group type: EXPERIMENTAL
Intervention: Revascularization in France and USA
Number of subjects: 13451
Study 16608859 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients' propensity for revascularization based on clinical factors
Number of subjects: 13451
Study 16608859 — intervention group
Group type: COMPARATOR
Intervention: Country-level factors
Number of subjects: 13451
Study 14616254 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral misoprostol (100 microg)
Number of subjects: 101
Study 14616254 — intervention group
Group type: COMPARATOR
Intervention: Vaginal misoprostol (25 microg)
Number of subjects: 101
Study 10790551 — intervention group
Group type: EXPERIMENTAL
Intervention: Micro-LC (three 2-mm trocars and one 10-mm trocar)
Number of subjects: 26
Study 10790551 — intervention group
Group type: COMPARATOR
Intervention: Laparoscopic cholecystectomy (LC) (two 10-mm and two 5-mm trocars)
Number of subjects: 26
Study 8988064 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg intramuscular ketorolac
Number of subjects: 522
Study 8988064 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 mg intramuscular ketorolac
Number of subjects: 522
Study 8988064 — intervention group
Group type: EXPERIMENTAL
Intervention: 60 mg intramuscular ketorolac
Number of subjects: 522
Study 8988064 — intervention group
Group type: EXPERIMENTAL
Intervention: 90 mg intramuscular ketorolac
Number of subjects: 522
Study 8988064 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 522
Study 1596720 — intervention group
Group type: EXPERIMENTAL
Intervention: Evening primrose oil; treatment improved fatty acid profiles towards normal; specific dosage and duration not mentioned.
Number of subjects: 0
Study 1596720 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified; no specific control intervention mentioned.
Number of subjects: 0
Study 3901218 — intervention group
Group type: EXPERIMENTAL
Intervention: Biostim (2 mg/day for the first month, 1 mg/day for the second and third months)
Number of subjects: 110
Study 3901218 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 110
Study 3901218 — intervention group
Group type: EXPERIMENTAL
Intervention: Biostim
Number of subjects: 110
Study 30928924 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined lumbar and sacral plexus block plus sedation
Number of subjects: 1086
Study 30928924 — intervention group
Group type: COMPARATOR
Intervention: General anaesthesia
Number of subjects: 1086
Study 29406521 — intervention group
Group type: EXPERIMENTAL
Intervention: Increasing number of low-energy-dense (LED) foods consumed
Number of subjects: 183
Study 29406521 — intervention group
Group type: COMPARATOR
Intervention: Decreasing number of high-energy-dense (HED) foods consumed
Number of subjects: 183
Study 29406521 — intervention group
Group type: EXPERIMENTAL
Intervention: Participants consuming ≤2 HED foods per day and ≥6.6 LED foods per day
Number of subjects: 183
Study 27368915 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensity-Modulated Radiotherapy (IMRT)
Number of subjects: 40
Study 27368915 — intervention group
Group type: COMPARATOR
Intervention: Three-Dimensional Conformal Radiotherapy (3D CRT)
Number of subjects: 40
Study 24916319 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness-based cognitive therapy with support to taper/discontinue antidepressant medication (MBCT-TS)
Number of subjects: 420
Study 24916319 — intervention group
Group type: COMPARATOR
Intervention: Maintenance antidepressant treatment (m-ADM)
Number of subjects: 420
Study 22249280 — intervention group
Group type: EXPERIMENTAL
Intervention: Two to four arms into the obturator foramen (TO)
Number of subjects: 230
Study 22249280 — intervention group
Group type: EXPERIMENTAL
Intervention: Fixed to the arcus tendineous fascia pelvis (FG)
Number of subjects: 230
Study 22249280 — intervention group
Group type: COMPARATOR
Intervention: Two arms into the retropubic space (RP)
Number of subjects: 230
Study 22455270 — intervention group
Group type: EXPERIMENTAL
Intervention: Misoprostol
Number of subjects: 50
Study 22455270 — intervention group
Group type: COMPARATOR
Intervention: PGF2alpha
Number of subjects: 50
Study 16675509 — intervention group
Group type: EXPERIMENTAL
Intervention: Ondansetron infusion at 250 ng/ml
Number of subjects: 0
Study 16675509 — intervention group
Group type: COMPARATOR
Intervention: Control (placebo)
Number of subjects: 0
Study 15324521 — intervention group
Group type: EXPERIMENTAL
Intervention: Rosuvastatin 10 mg plus ezetimibe 10 mg (n = 12)
Number of subjects: 40
Study 15324521 — intervention group
Group type: COMPARATOR
Intervention: Rosuvastatin 10 mg plus placebo (n = 12)
Number of subjects: 40
Study 15324521 — intervention group
Group type: COMPARATOR
Intervention: Ezetimibe 10 mg plus placebo (n = 8)
Number of subjects: 40
Study 15324521 — intervention group
Group type: COMPARATOR
Intervention: Placebo (n = 8)
Number of subjects: 40
Study 11275915 — intervention group
Group type: EXPERIMENTAL
Intervention: Medical therapy guided by a combination of clinical assessment and hemodynamic monitoring (PAC arm)
Number of subjects: 500
Study 11275915 — intervention group
Group type: COMPARATOR
Intervention: Medical therapy guided by clinical assessment alone (CLIN arm)
Number of subjects: 500
Study 11275915 — intervention group
Group type: EXPERIMENTAL
Intervention: PAC arm
Number of subjects: 500
Study 9284842 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium channel blockers (e.g., nifedipine, diltiazem, verapamil)
Number of subjects: 0
Study 9284842 — intervention group
Group type: EXPERIMENTAL
Intervention: Long acting formulations and newer calcium channel blockers
Number of subjects: 0
Study 9284842 — intervention group
Group type: COMPARATOR
Intervention: Other drug classes
Number of subjects: 0
Study 8330066 — intervention group
Group type: EXPERIMENTAL
Intervention: Active Specific Immunotherapy (A.S.I.) with autologous irradiated tumor cells mixed with BCG (10^7) injected intradermally on days 28 and 35 after surgery.
Number of subjects: 113
Study 8330066 — intervention group
Group type: EXPERIMENTAL
Intervention: Active Specific Immunotherapy (A.S.I.) with autologous irradiated tumor cells alone injected intradermally on day 42 after surgery.
Number of subjects: 113
Study 8330066 — intervention group
Group type: COMPARATOR
Intervention: Observation (Control group).
Number of subjects: 113
Study 3791362 — intervention group
Group type: EXPERIMENTAL
Intervention: Somophyllin‐CRT (500 mg)
Number of subjects: 8
Study 3791362 — intervention group
Group type: COMPARATOR
Intervention: Theo‐Dur (600 mg)
Number of subjects: 8
Study 31883730 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-reported hand hygiene after toileting
Number of subjects: 268
Study 31883730 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-reported hand hygiene before eating
Number of subjects: 268
Study 31883730 — intervention group
Group type: EXPERIMENTAL
Intervention: Desire for more information about hand hygiene
Number of subjects: 268
Study 31883730 — intervention group
Group type: EXPERIMENTAL
Intervention: Key themes from interviews
Number of subjects: 268
Study 30293833 — intervention group
Group type: EXPERIMENTAL
Intervention: Serratus Anterior Plane Block (SAPB)
Number of subjects: 108
Study 30293833 — intervention group
Group type: EXPERIMENTAL
Intervention: Pectoral Nerves II Block (Pecs II)
Number of subjects: 108
Study 30293833 — intervention group
Group type: COMPARATOR
Intervention: Intercostal Nerve Block (ICNB)
Number of subjects: 108
Study 27752827 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-behavioural therapy (CBT/MED) using R&R2ADHD programme
Number of subjects: 95
Study 27752827 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (TAU/MED)
Number of subjects: 95
Study 27752827 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-behavioural therapy (CBT/MED)
Number of subjects: 95
Study 25874243 — intervention group
Group type: EXPERIMENTAL
Intervention: NSAID (sodium diclofenac)
Number of subjects: 18
Study 25874243 — intervention group
Group type: EXPERIMENTAL
Intervention: Panacea (sodium diclofenac + carisoprodol + acetaminophen + caffeine)
Number of subjects: 18
Study 25874243 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study 24119858 — intervention group
Group type: EXPERIMENTAL
Intervention: Nortriptyline
Number of subjects: 110
Study 24119858 — intervention group
Group type: EXPERIMENTAL
Intervention: Sertraline
Number of subjects: 110
Study 22085440 — intervention group
Group type: EXPERIMENTAL
Intervention: Healthy Homework programme
Number of subjects: 97
Study 22085440 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 97
Study 19543121 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher quartiles of conscientiousness
Number of subjects: 370
Study 19543121 — intervention group
Group type: EXPERIMENTAL
Intervention: Depression
Number of subjects: 370
Study 17192499 — intervention group
Group type: EXPERIMENTAL
Intervention: Roflumilast 500 microg
Number of subjects: 15
Study 17192499 — intervention group
Group type: COMPARATOR
Intervention: Roflumilast 250 microg
Number of subjects: 15
Study 17192499 — intervention group
Group type: EXPERIMENTAL
Intervention: Roflumilast 250 microg and 500 microg
Number of subjects: 15
Study 16392539 — intervention group
Group type: EXPERIMENTAL
Intervention: random whole-body vibration (rWBV)
Number of subjects: 52
Study 16392539 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 52
Study 12126092 — intervention group
Group type: EXPERIMENTAL
Intervention: 99mTc-sestamibi
Number of subjects: 25
Study 12126092 — intervention group
Group type: COMPARATOR
Intervention: Control (normal controls, NC)
Number of subjects: 25
Study 11208239 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination diet (fruits, vegetables, low-fat dairy, low total and saturated fat)
Number of subjects: 459
Study 11208239 — intervention group
Group type: EXPERIMENTAL
Intervention: Fruits-and-vegetables diet
Number of subjects: 459
Study 11208239 — intervention group
Group type: COMPARATOR
Intervention: Control diet
Number of subjects: 459
Study 7826297 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.2% brimonidine tartrate
Number of subjects: 24
Study 7826297 — intervention group
Group type: COMPARATOR
Intervention: 0.5% timolol maleate
Number of subjects: 24
Study 7826297 — intervention group
Group type: COMPARATOR
Intervention: 0.25% betaxolol suspension
Number of subjects: 24
Study 7826297 — intervention group
Group type: COMPARATOR
Intervention: brimonidine vehicle
Number of subjects: 24
Study 2351301 — intervention group
Group type: EXPERIMENTAL
Intervention: Intragastric infusion of 160 ml autologous venous blood
Number of subjects: 6
Study 2351301 — intervention group
Group type: COMPARATOR
Intervention: Intragastric infusion of 160 ml egg white (Control)
Number of subjects: 6
Study 489262 — intervention group
Group type: EXPERIMENTAL
Intervention: Clomipramine
Number of subjects: 0
Study 489262 — intervention group
Group type: COMPARATOR
Intervention: Amitriptyline
Number of subjects: 0
Study 31248745 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher-Frequency Feedback
Number of subjects: 1125
Study 31248745 — intervention group
Group type: COMPARATOR
Intervention: Lower-Frequency Feedback
Number of subjects: 1125
Study 29051044 — intervention group
Group type: EXPERIMENTAL
Intervention: Glucose control therapy
Number of subjects: 0
Study 29051044 — intervention group
Group type: EXPERIMENTAL
Intervention: Ordinary least squares (OLS) regression models
Number of subjects: 0
Study 29051044 — intervention group
Group type: EXPERIMENTAL
Intervention: Sensitivity analyses
Number of subjects: 0
Study 29051044 — intervention group
Group type: COMPARATOR
Intervention: Random assignment to treatment
Number of subjects: 0
Study 26060821 — intervention group
Group type: EXPERIMENTAL
Intervention: Rebamipide
Number of subjects: 206
Study 26060821 — intervention group
Group type: COMPARATOR
Intervention: Untreated
Number of subjects: 206
Study 23808433 — intervention group
Group type: EXPERIMENTAL
Intervention: FOS enriched cookie
Number of subjects: 38
Study 23808433 — intervention group
Group type: COMPARATOR
Intervention: Control cookie
Number of subjects: 38
Study 21605236 — intervention group
Group type: EXPERIMENTAL
Intervention: Monophasic hyaluronic acid (mono-HA) filler
Number of subjects: 0
Study 21605236 — intervention group
Group type: COMPARATOR
Intervention: Biphasic hyaluronic acid (bi-HA) filler
Number of subjects: 0
Study 19372172 — intervention group
Group type: EXPERIMENTAL
Intervention: Forced-use group (standard rehabilitation + restraining sling on nonparetic arm for 6 hours per day)
Number of subjects: 30
Study 19372172 — intervention group
Group type: COMPARATOR
Intervention: Standard training group (standard rehabilitation only)
Number of subjects: 30
Study 17115981 — intervention group
Group type: EXPERIMENTAL
Intervention: Rofecoxib 50 mg
Number of subjects: 105
Study 17115981 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 105
Study 15337017 — intervention group
Group type: EXPERIMENTAL
Intervention: Cardiac support device (CSD)
Number of subjects: 10
Study 11343523 — intervention group
Group type: EXPERIMENTAL
Intervention: Salmonella abortus equi endotoxin (0.8 ng/kg)
Number of subjects: 20
Study 11343523 — intervention group
Group type: COMPARATOR
Intervention: Saline
Number of subjects: 20
Study 9552776 — intervention group
Group type: EXPERIMENTAL
Intervention: Sphenopalatine ganglion block (SPGB) with 4% lidocaine
Number of subjects: 23
Study 9552776 — intervention group
Group type: EXPERIMENTAL
Intervention: Trigger point injections (TPI) with 1% lidocaine
Number of subjects: 23
Study 9552776 — intervention group
Group type: COMPARATOR
Intervention: Sphenopalatine ganglion block (SPGB) with saline placebo
Number of subjects: 23
Study 7812583 — intervention group
Group type: EXPERIMENTAL
Intervention: Dressing foot wrap
Number of subjects: 25
Study 7812583 — intervention group
Group type: COMPARATOR
Intervention: Laminated foam boot (Lunax, BIO-SONICS)
Number of subjects: 25
Study 2685471 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 gms L-tryptophan
Number of subjects: 76
Study 2685471 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 76
Study 2685471 — intervention group
Group type: COMPARATOR
Intervention: No substances
Number of subjects: 76
Study 970882 — intervention group
Group type: EXPERIMENTAL
Intervention: Truncal vagotomy and antrectomy
Number of subjects: 22
Study 970882 — intervention group
Group type: EXPERIMENTAL
Intervention: Proximal gastric vagotomy
Number of subjects: 22
Study 970882 — intervention group
Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 22
Study 31064973 — intervention group
Group type: EXPERIMENTAL
Intervention: Fringed fall prevention program (6 sessions, 60 minutes group sessions, 20-30 minutes individual sessions)
Number of subjects: 97
Study 31064973 — intervention group
Group type: COMPARATOR
Intervention: Control group (no specific intervention details provided)
Number of subjects: 97
Study 28775061 — intervention group
Group type: EXPERIMENTAL
Intervention: High-Density Lipoprotein Cholesterol (HDL-C)
Number of subjects: 17661
Study 28775061 — intervention group
Group type: EXPERIMENTAL
Intervention: Apolipoprotein A-I (apoA-I)
Number of subjects: 17661
Study 25532068 — intervention group
Group type: EXPERIMENTAL
Intervention: Pyridoxamine dihydrochloride (Pyridorin™)
Number of subjects: 0
Study 22141358 — intervention group
Group type: EXPERIMENTAL
Intervention: Corticocancellous porcine bone grafting after extraction
Number of subjects: 40
Study 22141358 — intervention group
Group type: COMPARATOR
Intervention: No grafting after extraction
Number of subjects: 40
Study 20889142 — intervention group
Group type: EXPERIMENTAL
Intervention: Sleep Deprived Group
Number of subjects: 28
Study 20889142 — intervention group
Group type: COMPARATOR
Intervention: Sleep Control Group
Number of subjects: 28
Study 18561587 — intervention group
Group type: EXPERIMENTAL
Intervention: HESA-A tablet 25 mg/kg twice a day orally
Number of subjects: 28
Study 18561587 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 28
Study 15662490 — intervention group
Group type: EXPERIMENTAL
Intervention: Duloxetine (40 mg BID)
Number of subjects: 451
Study 15662490 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 451
Study 15662490 — intervention group
Group type: EXPERIMENTAL
Intervention: Duloxetine (study completers)
Number of subjects: 451
Study 15662490 — intervention group
Group type: COMPARATOR
Intervention: Placebo (study completers)
Number of subjects: 451
Study 12455078 — intervention group
Group type: EXPERIMENTAL
Intervention: AMI patients (postprocedural FFR)
Number of subjects: 48
Study 12455078 — intervention group
Group type: EXPERIMENTAL
Intervention: AMI patients with TIMI 2
Number of subjects: 48
Study 12455078 — intervention group
Group type: COMPARATOR
Intervention: Control group (stable angina pectoris)
Number of subjects: 48
Study 10631421 — intervention group
Group type: EXPERIMENTAL
Intervention: Pigtail CVC
Number of subjects: 203
Study 10631421 — intervention group
Group type: COMPARATOR
Intervention: Standard CVC
Number of subjects: 203
Study 7793450 — intervention group
Group type: EXPERIMENTAL
Intervention: Inositol 12 g/day
Number of subjects: 21
Study 7793450 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21
Study 1823741 — intervention group
Group type: EXPERIMENTAL
Intervention: Lovastatin
Number of subjects: 40
Study 1823741 — intervention group
Group type: EXPERIMENTAL
Intervention: Gemfibrozil
Number of subjects: 40
Study 1823741 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 7048671 — intervention group
Group type: EXPERIMENTAL
Intervention: Diethylcarbamazine (DEC) administration during daytime
Number of subjects: 0
Study 7048671 — intervention group
Group type: EXPERIMENTAL
Intervention: Routine diagnostic tool
Number of subjects: 0
Study 7048671 — intervention group
Group type: EXPERIMENTAL
Intervention: Preliminary screening method
Number of subjects: 0
Study 7048671 — intervention group
Group type: EXPERIMENTAL
Intervention: Evaluating parasitological response
Number of subjects: 0
Study 31318796 — intervention group
Group type: EXPERIMENTAL
Intervention: Uncorrected refractive error
Number of subjects: 2886
Study 31318796 — intervention group
Group type: EXPERIMENTAL
Intervention: Visual impairment
Number of subjects: 2886
Study 31318796 — intervention group
Group type: EXPERIMENTAL
Intervention: Presbyopia
Number of subjects: 2886
Study 31318796 — intervention group
Group type: EXPERIMENTAL
Intervention: Spectacle coverage for distance vision
Number of subjects: 2886
Study 31318796 — intervention group
Group type: EXPERIMENTAL
Intervention: Spectacle coverage for presbyopia
Number of subjects: 2886
Study 31318796 — intervention group
Group type: EXPERIMENTAL
Intervention: Barriers to spectacle uptake
Number of subjects: 2886
Study 29199186 — intervention group
Group type: EXPERIMENTAL
Intervention: HIIT
Number of subjects: 14
Study 29199186 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 14
Study 25516991 — intervention group
Group type: EXPERIMENTAL
Intervention: Ice application for 3 minutes before arterial puncture
Number of subjects: 0
Study 25516991 — intervention group
Group type: COMPARATOR
Intervention: Control group (no ice application)
Number of subjects: 0
Study 25516991 — intervention group
Group type: EXPERIMENTAL
Intervention: Ice application in naive group
Number of subjects: 0
Study 25516991 — intervention group
Group type: COMPARATOR
Intervention: Control group in naive group
Number of subjects: 0
Study 25516991 — intervention group
Group type: EXPERIMENTAL
Intervention: Ice application in experienced group
Number of subjects: 0